#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Diabetes and obesity - Issue 46/2023

Editorial

Prevalence of obesity and type 2 diabetes mellitus

Reviews

87

Screening for diabetic retinopathy in diabetic outpatient clinics using arteficial intelligence: a pilot project of the Slovak Diabetes Society

Viera Doničová

91

Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)

Jozef Lacka, Emil Martinka, Petra Ištokovičová, Tamara Vraždová, Peter Jackuliak

103

Benefit of early treatment with dapagliflozin in primary prevention in patients with type 2 diabetes mellitus

Jozef Lacka, Barbora Lacková

113

Cardio-renal and metabolic benefits of empagliflozin: additional indication and change in indication restrictions

Ingrid Dravecká

118

Obesity and heart failure with preserved ejection fraction – dapagliflozin also shows clinical benefit here

Ján Murín

125

The SGLT2 inhibitor canagliflozin: a comprehensive effect in the treatment of type 2 diabetes mellitus

Zbynek Schroner

News

127

International Peace Marathon – try once, love forever!

Olga Bobelová

News

128

Summary of the 59th Annual Congress of the European Association for the Study of Diabetes

Peter Novodvorský

Personalities

130

MUDr. Martina Merčiaková, MBA – portrét ambulantnej diabetologičky

131

MUDr. Ján Truban – portrét ambulantného diabetológa

Personal news

133

Remembrance of JUDr. Eva Madajová

134

In memoriam MUDr. Evy Virčíkovej

Diabetes and obesity

Issue 46

2023 Issue 46

Most read in this issue

#ADS_BOTTOM_SCRIPTS#